Brought to you by 
Altea licenses SpectRx technology for monitoring applications
19 Nov 1999
Executive Summary
Start-up drug delivery company, Altea Technologies granted SpectRx (noninvasive diagnostic monitoring systems) an exclusive license to its technology for all transdermal monitoring applications, but retained exclusive rights to delivery applications.
Deal Industry
- Biotechnology
- Medical Devices
-
Medical Devices
- Diagnostic Equipment & Supplies
Deal Status
- Final
Deal Type
-
Alliance
- Includes Contract
- Includes Equity
- R&D and Marketing (Licensing)
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Altea licenses SpectRx technology for monitoring applications
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice